ClinicalTrials.gg
RecruitingNCT02797457ARMEDICUpdated May 8, 2024

Medical Economic Evaluation of Bilateral Allograft of Hands and Forearms

An interventional study of Bilateral allograft of the hands and forearms. and Prosthetic forehands in Bilateral Traumatic Amputation of Upper Limbs, sponsored by Hospices Civils de Lyon. Recruiting at 11 sites in France. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-05-08.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2018; still recruiting 8 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The double amputation of the forearms is a rare handicap that seriously impacts the autonomy and the quality of life of patients, social and familial exclusion, and dependence on third parties for everyday activities.

The management of these patients is nearly exclusively through the use of prostheses. Certain patients refuse this solution, or remain penalized by the absence of sensitivity , the lack of precision in movements, and body image issues related to the amputation; the double graft of hands and forearms may, in this circumstance, be the only solution.

Since January 2000, date of the first double hand graft, six bilateral grafts of hands have been performed at the Hospices Civils de Lyon. This first study reported the feasibility of the graft. The functional results obtained after the double transplant have allowed patients to recover complete autonomy for everyday activities, at the price of an immunosuppressive treatment. We have found that these very good functional results are maintained over time and, for a certain number of patients, to return to work which is a factor of social integration.

The rate of medical complications (metabolic, infectious, oncological), essentially related to the immunosuppressive treatment, is not greater to that found for other types of graft, but are considered as a limiting factor for the development of this strategy. These results are confirmed by international experience that is of the same order. Only a few rare cases of re-amputation have been reported in patients for whom the immunosuppressive treatment was discontinued or following vascular thrombosis.

A new study is required to continue this evaluation and to compare double graft to prostheses in terms costs, quality of life, usefulness, satisfaction, autonomy, and social integration. The results of this study will allow the placement of these strategies in the management of patients with double amputation of the hands and forearms.

02

Conditions studied

  • Bilateral Traumatic Amputation of Upper Limbs

Browse trials for

Keywords

  • Bilateral amputation of the forearms
  • Bilateral allograft
  • Prosthetic forehands
  • Medical economic evaluation
03

In context

Amputation, Traumatic

112 studies on the registry are indexed under Amputation, Traumatic; 24 are open to participants now.

This study's planned enrollment of 40 is above the median of 15 across 75 interventional studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Inclusion criteria common to the 2 groups of patients (allograft group and protheses group):

  • Adult aged 18 to 60 years
  • Double amputated of both forearms

Transplant eligibility criteria (for allograft group)

  • Minimum interval between amputation and graft of three months (no maximal delay)
  • Absence of previous psychiatric history contraindicating the graft and psychological maturity, according to two psychiatrists who have evaluated the patient
  • No previous history of malignant tumor in remission for less than 5 years
  • American Society of Anesthesiology (ASA) score ≤ 2
  • (NYHA) grade ≥ 1
  • ≥ 60 ml/min/1.73m²
  • Absence of badly controlled sever hypertension

Exclusion criteria

Exclusion Criteria:

  • Mono amputated patients
  • Malignant tumor or previous history of malignant tumor for which the risk of recurrence at 5 years is greater than 5%
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Creatinine clearance (CrCl)

How quickly the kidneys clear creatinine, a waste product, from the blood. A study may estimate it from a blood test with age, weight and sex (often by the Cockcroft–Gault formula), or measure it using blood and urine collected over a set time. Given in mL/min; higher is better.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Other
    Allograft

    Bilateral allograft of the hands and forearms.

    Procedure: Bilateral allograft of the hands and forearms.

  • Other
    Prostheses

    Prosthetic forehands

    Procedure: Prosthetic forehands

Interventions

  • ProcedureBilateral allograft of the hands and forearms.

    Bilateral allograft of the hands and forearms.

  • ProcedureProsthetic forehands

    Prosthetic forehands

06

What researchers measure

Primary outcomes

  1. Treatment cost

    Treatment cost of double amputated patients by bilateral allograft of the hands and forearms or by prostheses

    Time frame: 36 months

07

Study locations

11 of 11 sites recruiting
  • Serice de Rééducation et Réadaptation fonctionnelles - Centre Jacques Calvé - Fondation Hopale
    Berck, 62600, France
    Recruiting
    • Frédéric CHARLATE, MD · Contact
    • Frédéric CHARLATE, MD · Principal investigator
  • Service de Médecine Physique et Réadapatation fonctionnelle - Centre de Médecine Physique et de Réadaptation La Tour de Gassies
    Bruges, 33520, France
    Recruiting
    • Rémi KLOTZ, MD · Contact
    • Rémi KLOTZ, MD · Principal investigator
  • Serice de Médecine Physique et Réadaptation - Hôpital d'Instruction des Armées Percy
    Clamart, 92140, France
    Recruiting
    • Eric LAPEYRE, MD · Contact
    • Eric LAPEYRE, MD · Principal investigator
  • Serice de Rééducation et Réadaptation fonctionnelles - Centre l'Espoir
    Lille, 59260, France
    Recruiting
    • Hervé DELAHAYE, MD · Contact
    • Hervé DELAHAYE, MD · Principal investigator
  • Serice de Médecine Physique et Réadaptation des patients amputés - Centre Médico-Chirugical et de Réadaptation des Massues
    Lyon, 69005, France
    Recruiting
    • Isabelle LAROYENNE, MD · Contact
    • Isabelle LAROYENNE, MD · Principal investigator
  • Service de Chirurgie de la Transplantation - Hôpital Edouard Herriot - Hospices Civils de Lyon
    Lyon, 69427, France
    Recruiting
    • Lionel BADET, MD · Contact
    • Lionel BADET, MD · Principal investigator
  • Serice de Rééducation et Réadaptation fonctionnelles - Centre Médical de Rééducation Romans Ferrari
    Miribel, 01700, France
    Recruiting
    • Renaud TAVERNIER, MD · Contact
    • Renaud TAVERNIER, MD · Principal investigator
  • Service de Médecine Physique et Réadaptation - Institut Régional de Médecine Physique et de Réadaptation
    Nancy, 54042, France
    Recruiting
    • Jean PAYSANT, MD · Contact
    • Jean PAYSANT, MD · Principal investigator
  • Serice de Rééducation fonctionnelle - Centre Mutualiste de Rééducation et Réadaptation fonctionnelles de Kerpape
    Ploemeur, 56275, France
    Recruiting
    • Pierre VERSCHOORE, MD · Contact
    • Pierre VERSCHOORE, MD · Principal investigator
  • Serice de Rééducation et Réadaptation fonctionnelles - Hôpital Henry-Gabrielle - Hospices Civils de Lyon
    Saint-Genis-Laval, 69230, France
    Recruiting
    • Gilles RODE, MD · Contact
    • Gilles RODE, MD · Principal investigator
  • Service de Rééducation et appareillage - Institut Robert Merle d'Aubigné
    Valenton, 94460, France
    Recruiting
    • Florence GUILLOU, MD · Contact
    • Florence GUILLOU, MD · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02797457
Responsible party
Sponsor
First posted
Jun 13, 2016
Start date
Oct 16, 2018
Primary completion
Oct 16, 2031 (estimated)
Completion
Oct 16, 2031 (estimated)
Last update
May 8, 2024

Study contacts

Lionel BADET, M
Contact
lionel.badet@chu-lyon.fr
4 72 11 91 91 ext. +33

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion